The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2089–2112 of 3,535
Cardiff Oncology, Inc. has announced a KOL webinar scheduled for April 30, 2026, to discuss the promising data from an investigator-initiated trial evaluating t...
Intellia Therapeutics has initiated a rolling submission of a biologics license application (BLA) to the FDA for **lonvo-z** (formerly NTLA-2002), an innovative...
Intellia Therapeutics has announced promising topline results from the Phase 3 HAELO trial of **lonvoguran ziclumeran (lonvo-z)**, an innovative CRISPR gene-edi...
Ocular Therapeutix, Inc. has announced its participation in several key scientific and investor conferences throughout May 2026, highlighting its commitment to...
Sionna Therapeutics has successfully completed enrollment for its **PreciSION CF Phase 2a proof-of-concept trial**, evaluating **SION-719**, a first-in-class **...
Eli Lilly's acquisition of Ajax Therapeutics may lead to a new treatment for blood cancers, offering hope for better outcomes.
Eli Lilly and Company has announced its acquisition of Ajax Therapeutics, focusing on Ajax's lead candidate, **AJ1-11095**, a first-in-class **Type II JAK2 inhi...
A recent study published in **Nature Health** reveals a **150% increase in cancer risk** associated with living in pesticide-heavy environments, challenging the...
Researchers have identified the **RIPK3-MLKL axis** as a critical mediator of **hematopoietic stem cell (HSC) aging**, revealing how stress responses contribute...
Recent meta-analysis findings challenge the efficacy of **anti-amyloid immunotherapies** in treating Alzheimer's disease, particularly among patients with mild...
Relay Therapeutics has announced the advancement of **zovegalisib** in combination with **atirmociclib** and an **aromatase inhibitor** (AI) into Phase 3 trials...
A growing body of evidence—anchored in telomere biology, cardiovascular epidemiology, and neuroendocrinology—positions regular sexual activity as a measurable contributor to healthspan, with data showing up to 49% lower all-cause mortality among sexually active adults compared to those who are largely abstinent...
BudPop has launched a new line of **Delta-9 THC + CBG + CBC + CBN gummies** aimed at enhancing adult intimacy and addressing stress-related libido issues. These...
Calluna Pharma has successfully completed enrollment for its global Phase 2 AURORA study of **CAL101**, a monoclonal antibody targeting the damage-associated pr...
Insilico Medicine has announced the nomination of **ISM0387**, marking it as the first preclinical candidate from the UAE and the company's 30th AI-supported ca...
Nuritas has initiated a **double-blinded randomized controlled trial (NCT07528469)** to evaluate the efficacy of **PeptiStrong**, a fava bean-derived peptide, i...
Research from the **BMJ Medicine** has revealed that **diversifying exercise routines**—rather than simply increasing the volume of physical activity—can signif...
A recent analysis led by researchers in England highlights the alarming **risk of heat-related mortality** among residents in nursing and residential care homes...
Vigorous exercise can lower arterial stiffness, benefiting heart health in older adults.
A new tool can help predict life expectancy for older men with prostate cancer based on their health status.
Low socioeconomic status increases frailty risk, but lifestyle changes can help.
New guidelines aim to help caregivers manage medications safely for people with dementia.
The **C3 Davos of Healthcare™ Silicon Valley Summit**, commencing on April 27, 2026, at the Plug and Play Tech Center, aims to redefine the future of health inn...
A pivotal event in health innovation, the **C3 Davos of Healthcare™ Silicon Valley Summit**, is set to commence on April 27, 2026, at the Plug and Play Tech Cen...
